LAURETTA CHIGBOH: Open Payments
NPI 1417591488 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 58 payments from 14 companies in 2025. Trend: 2023 $1,167 · 2024 $1,217 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $307 |
| AstraZeneca Pharmaceuticals LP | 6 | $157 |
| Merck Sharp & Dohme LLC | 9 | $138 |
| Lilly USA, LLC | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Corcept Therapeutics | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: Wegovy, FARXIGA, VERQUVO, Ozempic, MOUNJARO, JARDIANCE, Kerendia, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
